267 related articles for article (PubMed ID: 8856831)
21. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
Maneuf YP; Nash JE; Crossman AR; Brotchie JM
Eur J Pharmacol; 1996 Jul; 308(2):161-4. PubMed ID: 8840127
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
[TBL] [Abstract][Full Text] [Related]
23. WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction.
Robinson L; Goonawardena AV; Pertwee R; Hampson RE; Platt B; Riedel G
Behav Brain Res; 2010 Apr; 208(2):584-92. PubMed ID: 20079375
[TBL] [Abstract][Full Text] [Related]
24. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
Lichtman AH; Martin BR
Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
26. Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys.
Nakamura-Palacios EM; Winsauer PJ; Moerschbaecher JM
Behav Pharmacol; 2000 Aug; 11(5):377-86. PubMed ID: 11103889
[TBL] [Abstract][Full Text] [Related]
27. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
Smith FL; Fujimori K; Lowe J; Welch SP
Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941
[TBL] [Abstract][Full Text] [Related]
28. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.
Nava F; Carta G; Battasi AM; Gessa GL
Br J Pharmacol; 2000 Jul; 130(6):1201-10. PubMed ID: 10903956
[TBL] [Abstract][Full Text] [Related]
29. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
30. delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Wise LE; Varvel SA; Selley DE; Wiebelhaus JM; Long KA; Middleton LS; Sim-Selley LJ; Lichtman AH
Psychopharmacology (Berl); 2011 Oct; 217(4):485-94. PubMed ID: 21559804
[TBL] [Abstract][Full Text] [Related]
31. Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
Schulze DR; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2012 Aug; 222(3):425-38. PubMed ID: 22374253
[TBL] [Abstract][Full Text] [Related]
32. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
Delatte MS; Winsauer PJ; Moerschbaecher JM
Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
[TBL] [Abstract][Full Text] [Related]
33. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
34. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
35. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats.
Xiong ZQ; Tang XC
Pharmacol Biochem Behav; 1995; 51(2-3):415-9. PubMed ID: 7667362
[TBL] [Abstract][Full Text] [Related]
36. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
[TBL] [Abstract][Full Text] [Related]
37. Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats.
Egashira N; Mishima K; Iwasaki K; Fujiwara M
Brain Res; 2002 Oct; 952(2):239-45. PubMed ID: 12376185
[TBL] [Abstract][Full Text] [Related]
38. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
Pistis M; Ferraro L; Pira L; Flore G; Tanganelli S; Gessa GL; Devoto P
Brain Res; 2002 Sep; 948(1-2):155-8. PubMed ID: 12383968
[TBL] [Abstract][Full Text] [Related]
39. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
Beardsley PM; Martin BR
Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
[TBL] [Abstract][Full Text] [Related]
40. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
Lichtman AH
Eur J Pharmacol; 2000 Sep; 404(1-2):175-9. PubMed ID: 10980277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
